Skip to main content

Table 2 Comparison of designed peptides for various NDV genotypes with genotypes II (LaSota) and XII

From: Identification and evaluation in-vitro of conserved peptides with high affinity to MHC-I as potential protective epitopes for Newcastle disease virus vaccines

  1. Variations of genotype XII: aChina (MT301958.1), bPeru (JN800306.2, KR732614.1). Amino acid variations in the 5 tested peptides against genotypes II (live vaccines) and XII (highly virulent) genomes are highlighted in red